MediLumine’s Mvivo Au contrast agent was injected at a dose of 0.1 ml in nude mice grafted with Sdhb(-/-) and scanned with Mediso nanoScan PET/CT at Inserm U970, Paris, France (Viel T, Yoganathan T, Perez-Liva M, Tavitian B). 3D CT images of tumor vasculature were generated with Amira 3D visualization and analysis software for life sciences (Thermo Fisher Scientific).

MediLumine Expands U.S. Access Through Partnership with Braintree Scientific
MediLumine is pleased to announce a new distribution partnership with Braintree Scientific, a company recognized for its long-standing contribution to life science research. This collaboration
